market research Archives | Page 7 of 10

Key Events in the Evolution of iPSC Products that You Need to Know

June 19, 2015 By Cade Hildreth (CEO) Leave a Comment

Developing induced pluripotent stem cell (iPSC) products requires a thorough understanding of the evolution of iPSC research advances. Because the cell type was recently discovered in 2006, the following presents a decade-long timeline of key events in the discovery and evolution of induced pluripotent stem cell products.

The research events below drove forward interest in the use of iPSCs for basic research and clinical applications. These events are the reason that the first clinical trial involving the implantation of iPSCs into humans was initiated in 2013, to assess the capacity of the cell type to treat loss of eyesight due to macular degeneration.

For this reason, stem cell company executives and stem cell industry investors will be better suited to make future decisions about iPSC products if they have a historical understanding of the recent past and the rate at which research advances with the cell type accelerated. [Read more…]

[Timeline] Key Events in the Production of Induced Pluripotent Stem Cells

June 18, 2015 By Cade Hildreth (CEO) Leave a Comment

When assessing the market potential for induced pluripotent stem cells (iPSCs), it is important to consider where the research began, when it accelerated, and where it is at the current point in time.

Timeline of Key iPSC Production Events

The following is a timeline of the key events in the production of iPSCs, beginning with their discovery in 2006. For research product companies interested in dominating the iPSC products marketplace, it is critical to understand the different production methods for iPSCs, the chronological order of the introduction of methodologies, and the inventors who first performed each.

The reason for this is several-fold: [Read more…]

Adult and Fetal Isolation Sources for Mesenchymal Stem Cells (MSCs)

June 1, 2015 By Cade Hildreth (CEO) Leave a Comment

Mesenchymal stem cells can be derived from a diverse range of tissues. Originally, Friedenstein et al. isolated MSCs from the bone marrow (BM) and stroma of the spleen and thymus.[1][2] MSCs have since been derived from tissues as varied as the brain, spleen, liver, kidney, lung, bone marrow, muscle, thymus, and pancreas.[3] However, bone marrow aspirates are still considered to be the most convenient and enriched source of MSCs.[4]

Fetal tissue also contains MSCs, with common sources including umbilical cord blood and fetal placenta. These sources may represent ontogenetically younger MSCs. Evidence exists that MSCs from fetal sources can undergo more cell divisions before they reach senescence than MSCs from adult tissue.[5] [Read more…]

Mesenchymal Stem Cell (MSC) Products – The Cost of Winning Search Terms Online

May 20, 2015 By Cade Hildreth (CEO) Leave a Comment

Marketing Cost Analysis for “Mesenchymal Stem Cell”

Because Google now controls over 50% of online searches, it is the single best resource available for analyzing online search behavior within the mesenchymal stem cell (MSC) market.

Identifying the cost of winning search terms related to MSCs is an important analysis for company executives to conduct, because it allows for the planning of cost-effective Google AdWords campaigns and because it reveals existing levels of market competition for the sale of MSC products and services. [Read more…]

Data is boring. Put your trust in a new-age market research firm.

April 3, 2015 By Cade Hildreth (CEO) Leave a Comment

“Data is boring. Put your trust in a new-age market research firm. We’re innovative, fast, and trained in applying bioinformatics – the science of analyzing complex biological data – to the field of market research.